Veerhealth Care sets date for FY26 results and dividend review
The company will meet to approve audited financial results for the year ended March 31, 2026, and consider a dividend payout.
— 1 earlier story on Veerhealth Care Ltd. →What's new
- Board meeting scheduled to approve FY26 audited financial results.
- Directors will consider a dividend recommendation for the fiscal year.
- Trading window closure and reopening dates confirmed per standard protocol.
Why this matters
This is a routine regulatory filing. It contains no new information beyond the standard schedule for year-end financial reporting.
What we're watching
- The final audited figures for FY26.
- The quantum of any proposed dividend.
- Any commentary on growth plans for the new fiscal year.
The full read
Veerhealth Care has scheduled a board meeting to approve its audited financial results for the year ended March 31, 2026. The board will also consider a dividend recommendation for the fiscal year.
Routine.
This filing is a standard procedural requirement under SEBI Listing Regulations and provides no new or unexpected information. The company has also confirmed the trading window reopening date as part of its routine compliance, ensuring that all internal stakeholders are aligned with the upcoming disclosure schedule for the full fiscal year.
Questions answered
- What is the purpose of this board meeting?
- The board is meeting to approve the audited financial results for the quarter and year ended March 31, 2026.
- Will there be a dividend announcement?
- The board will consider a dividend recommendation during the meeting.
- Is this filing unusual?
- No. This is a standard procedural requirement under SEBI Listing Regulations.
Story so far
All notes on NIYATILEAS →- 25 May 2026 · 3:17 PM IST Veerhealth Care sets date for FY26 results and dividend review
- today Veerhealth's annual revenue nearly doubles to ₹32.5 cr, but Q4 flips to a loss